149 related articles for article (PubMed ID: 18976908)
1. Modulation of PPAR receptor subtype selectivity of the ligands: aliphatic chain vs aromatic ring as a spacer between pharmacophore and the lipophilic moiety.
Pingali H; Jain M; Shah S; Patil P; Makadia P; Zaware P; Sairam KV; Jamili J; Goel A; Patel M; Patel P
Bioorg Med Chem Lett; 2008 Dec; 18(24):6471-5. PubMed ID: 18976908
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity studies on 1,3-dioxane-2-carboxylic acid derivatives, a novel class of subtype-selective peroxisome proliferator-activated receptor alpha (PPARalpha) agonists.
Asaki T; Aoki T; Hamamoto T; Sugiyama Y; Ohmachi S; Kuwabara K; Murakami K; Todo M
Bioorg Med Chem; 2008 Jan; 16(2):981-94. PubMed ID: 17964792
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of novel oxazole containing 1,3-dioxane-2-carboxylic acid derivatives as PPAR alpha/gamma dual agonists.
Pingali H; Jain M; Shah S; Makadia P; Zaware P; Goel A; Patel M; Giri S; Patel H; Patel P
Bioorg Med Chem; 2008 Aug; 16(15):7117-27. PubMed ID: 18625559
[TBL] [Abstract][Full Text] [Related]
4. Modulation of PPAR subtype selectivity. Part 2: Transforming PPARα/γ dual agonist into α selective PPAR agonist through bioisosteric modification.
Zaware P; Shah SR; Pingali H; Makadia P; Thube B; Pola S; Patel D; Priyadarshini P; Suthar D; Shah M; Jamili J; Sairam KV; Giri S; Patel L; Patel H; Sudani H; Patel H; Jain M; Patel P; Bahekar R
Bioorg Med Chem Lett; 2011 Jan; 21(2):628-32. PubMed ID: 21195611
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a highly orally bioavailable c-5-[6-(4-Methanesulfonyloxyphenyl)hexyl]-2-methyl-1,3-dioxane-r-2-carboxylic acid as a potent hypoglycemic and hypolipidemic agent.
Pingali H; Jain M; Shah S; Basu S; Makadia P; Goswami A; Zaware P; Patil P; Godha A; Giri S; Goel A; Patel M; Patel H; Patel P
Bioorg Med Chem Lett; 2008 Oct; 18(20):5586-90. PubMed ID: 18805005
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a novel class of 1,3-dioxane-2-carboxylic acid derivatives as subtype-selective peroxisome proliferator-activated receptor alpha (PPARalpha) agonists.
Aoki T; Asaki T; Hamamoto T; Sugiyama Y; Ohmachi S; Kuwabara K; Murakami K; Todo M
Bioorg Med Chem Lett; 2008 Mar; 18(6):2128-32. PubMed ID: 18280733
[TBL] [Abstract][Full Text] [Related]
7. Discovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid (BMS-687453).
Li J; Kennedy LJ; Shi Y; Tao S; Ye XY; Chen SY; Wang Y; Hernández AS; Wang W; Devasthale PV; Chen S; Lai Z; Zhang H; Wu S; Smirk RA; Bolton SA; Ryono DE; Zhang H; Lim NK; Chen BC; Locke KT; O'Malley KM; Zhang L; Srivastava RA; Miao B; Meyers DS; Monshizadegan H; Search D; Grimm D; Zhang R; Harrity T; Kunselman LK; Cap M; Kadiyala P; Hosagrahara V; Zhang L; Xu C; Li YX; Muckelbauer JK; Chang C; An Y; Krystek SR; Blanar MA; Zahler R; Mukherjee R; Cheng PT; Tino JA
J Med Chem; 2010 Apr; 53(7):2854-64. PubMed ID: 20218621
[TBL] [Abstract][Full Text] [Related]
8. Improvement of the transactivation activity of phenylpropanoic acid-type peroxisome proliferator-activated receptor pan agonists: effect of introduction of fluorine at the linker part.
Kasuga J; Oyama T; Hirakawa Y; Makishima M; Morikawa K; Hashimoto Y; Miyachi H
Bioorg Med Chem Lett; 2008 Aug; 18(16):4525-8. PubMed ID: 18662876
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of novel bis-oximinoalkanoic acids as potent PPAR alpha agonists.
Pingali H; Jain M; Shah S; Zaware P; Makadia P; Pola S; Thube B; Patel D; Patil P; Priyadarshini P; Suthar D; Shah M; Giri S; Patel P
Bioorg Med Chem Lett; 2010 Feb; 20(3):1156-61. PubMed ID: 20022492
[TBL] [Abstract][Full Text] [Related]
10. Discovery of highly potent and selective benzyloxybenzyl-based peroxisome proliferator-activator receptor (PPAR) delta agonists.
Bratton LD; Filzen GF; Geyer A; Hoffman JK; Lu G; Pulaski J; Trivedi BK; Unangst PC; Xu X
Bioorg Med Chem Lett; 2007 Jul; 17(13):3624-9. PubMed ID: 17498950
[TBL] [Abstract][Full Text] [Related]
11. Novel oxazole containing phenylpropane derivatives as peroxisome proliferator activated receptor agonists with hypolipidemic activity.
Pingali H; Raval S; Raval P; Makadia P; Zaware P; Goel A; Suthar D; Jain M; Patel P
Pharmazie; 2008 Jul; 63(7):497-502. PubMed ID: 18717481
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and evaluation of a novel series of alpha-substituted phenylpropanoic acid derivatives as human peroxisome proliferator-activated receptor (PPAR) alpha/delta dual agonists for the treatment of metabolic syndrome.
Kasuga J; Yamasaki D; Araya Y; Nakagawa A; Makishima M; Doi T; Hashimoto Y; Miyachi H
Bioorg Med Chem; 2006 Dec; 14(24):8405-14. PubMed ID: 16996742
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and structure-activity relationship of carbamate-tethered aryl propanoic acids as novel PPARalpha/gamma dual agonists.
Kim NJ; Lee KO; Koo BW; Li F; Yoo JK; Park HJ; Min KH; Lim JI; Kim MK; Kim JK; Suh YG
Bioorg Med Chem Lett; 2007 Jul; 17(13):3595-8. PubMed ID: 17507225
[TBL] [Abstract][Full Text] [Related]
14. Recent progress in research on peroxisome proliferator-activated receptor alpha-selective ligands.
Miyachi H
IDrugs; 2004 Aug; 7(8):746-54. PubMed ID: 15334308
[TBL] [Abstract][Full Text] [Related]
15. Quinoline-based derivatives of pirinixic acid as dual PPAR alpha/gamma agonists.
Popescu L; Rau O; Böttcher J; Syha Y; Schubert-Zsilavecz M
Arch Pharm (Weinheim); 2007 Jul; 340(7):367-71. PubMed ID: 17610302
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a novel class of 2-mercaptohexanoic acid derivatives as highly active PPARalpha agonists.
Zettl H; Steri R; Lämmerhofer M; Schubert-Zsilavecz M
Bioorg Med Chem Lett; 2009 Aug; 19(15):4421-6. PubMed ID: 19556125
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of novel constrained meta-substituted phenyl propanoic acids as peroxisome proliferator-activated receptor alpha and gamma dual agonists.
Suh YG; Kim NJ; Koo BW; Lee KO; Moon SH; Shin DH; Jung JW; Paek SM; Chang DJ; Li F; Kang HJ; Le TV; Chae YN; Shin CY; Kim MK; Lim JI; Ryu JS; Park HJ
J Med Chem; 2008 Oct; 51(20):6318-33. PubMed ID: 18826205
[TBL] [Abstract][Full Text] [Related]
18. 7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists.
Matin A; Gavande N; Kim MS; Yang NX; Salam NK; Hanrahan JR; Roubin RH; Hibbs DE
J Med Chem; 2009 Nov; 52(21):6835-50. PubMed ID: 19807106
[TBL] [Abstract][Full Text] [Related]
19. Alpha-alkyl substituted pirinixic acid derivatives as potent dual agonists of the peroxisome proliferator activated receptor alpha and gamma.
Rau O; Syha Y; Zettl H; Kock M; Bock A; Schubert-Zsilavecz M
Arch Pharm (Weinheim); 2008 Mar; 341(3):191-5. PubMed ID: 18275039
[TBL] [Abstract][Full Text] [Related]
20. Switching subtype-selectivity: Fragment replacement strategy affords novel class of peroxisome proliferator-activated receptor α/δ (PPARα/δ) dual agonists.
Shioi R; Okazaki S; Noguchi-Yachide T; Ishikawa M; Makishima M; Hashimoto Y; Yamaguchi T
Bioorg Med Chem Lett; 2017 Jul; 27(14):3131-3134. PubMed ID: 28539218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
